Healthcare provider profile · identity verified

Keith Wolfe, D.O.

Family Practice · SENECA, PA · NPI 1770745754

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	792	208
Lisinopril	Lisinopril	757	212
Pantoprazole Sodium	Pantoprazole Sodium	441	121
Losartan Potassium	Losartan Potassium	414	110
Omeprazole	Omeprazole	347	88
Amlodipine Besylate	Amlodipine Besylate	329	98
Levothyroxine Sodium	Levothyroxine Sodium	315	84
Hydrochlorothiazide	Hydrochlorothiazide	286	89
Metformin Hcl	Metformin Hcl	286	73
Montelukast Sodium	Montelukast Sodium	285	70
Metoprolol Succinate	Metoprolol Succinate	261	73
Simvastatin	Simvastatin	239	52
Jardiance	Empagliflozin	193	42
Duloxetine Hcl	Duloxetine Hcl	187	56
Gabapentin	Gabapentin	186	46
Meloxicam	Meloxicam	176	54
Albuterol Sulfate Hfa	Albuterol Sulfate	175	90
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	174	36
Spironolactone	Spironolactone	156	48
Fluticasone Propionate	Fluticasone Propionate	151	63
Eliquis	Apixaban	146	33
Furosemide	Furosemide	146	45
Sertraline Hcl	Sertraline Hcl	144	43
Tamsulosin Hcl	Tamsulosin Hcl	137	39
Trazodone Hcl	Trazodone Hcl	136	44
Glipizide Er	Glipizide	126	37
Trulicity	Dulaglutide	122	18
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	119	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	95	29
Breo Ellipta	Fluticasone/Vilanterol	90	17
Celecoxib	Celecoxib	89	23
Clopidogrel	Clopidogrel Bisulfate	77	21
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	76	12
Pravastatin Sodium	Pravastatin Sodium	76	29
Warfarin Sodium	Warfarin Sodium	73	16
Alendronate Sodium	Alendronate Sodium	70	17
Prednisone	Prednisone	67	55
Spiriva Respimat	Tiotropium Bromide	65	suppressed
Diclofenac Sodium	Diclofenac Sodium	62	26
Ropinirole Hcl	Ropinirole Hcl	62	18
Metoprolol Tartrate	Metoprolol Tartrate	61	23
Rosuvastatin Calcium	Rosuvastatin Calcium	57	17
Citalopram Hbr	Citalopram Hydrobromide	56	21
Venlafaxine Hcl Er	Venlafaxine Hcl	54	15
Baclofen	Baclofen	50	11
Ezetimibe	Ezetimibe	50	11
Xarelto	Rivaroxaban	49	suppressed
Ozempic	Semaglutide	46	17
Tradjenta	Linagliptin	44	14
Carvedilol	Carvedilol	43	13
Nystatin	Nystatin	42	23
Sucralfate	Sucralfate	41	suppressed
Allopurinol	Allopurinol	40	suppressed
Buspirone Hcl	Buspirone Hcl	40	16
Naproxen	Naproxen	40	14
Nortriptyline Hcl	Nortriptyline Hcl	40	17
Doxycycline Hyclate	Doxycycline Hyclate	38	36
Donepezil Hcl	Donepezil Hcl	37	suppressed
Famotidine	Famotidine	37	17
Fluoxetine Hcl	Fluoxetine Hcl	37	11
Bupropion Hcl	Bupropion Hcl	36	12
Paroxetine Hcl	Paroxetine Hcl	36	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	35	15
Oxybutynin Chloride Er	Oxybutynin Chloride	35	11
Clonidine Hcl	Clonidine Hcl	34	suppressed
Potassium Chloride	Potassium Chloride	34	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	34	suppressed
Topiramate	Topiramate	33	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	32	suppressed
Pregabalin	Pregabalin	32	suppressed
Ondansetron Odt	Ondansetron	30	11
Solifenacin Succinate	Solifenacin Succinate	30	suppressed
Ventolin Hfa	Albuterol Sulfate	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	16
Januvia	Sitagliptin Phosphate	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Clonazepam	Clonazepam	27	suppressed
Ibuprofen	Ibuprofen	26	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	22
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	22	suppressed
Mirtazapine	Mirtazapine	22	11
Tramadol Hcl	Tramadol Hcl	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Glipizide	Glipizide	19	suppressed
Mupirocin	Mupirocin	18	16
Propranolol Hcl	Propranolol Hcl	18	suppressed
Atenolol	Atenolol	17	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Bumetanide	Bumetanide	17	suppressed
Clonidine	Clonidine	16	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Premarin	Estrogens, Conjugated	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Fluconazole	Fluconazole	15	12
Tresiba Flextouch U-200	Insulin Degludec	15	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	14	suppressed
Budesonide Dr	Budesonide	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Azithromycin	Azithromycin	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Linzess	Linaclotide	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error